Lv45
620 积分 2022-08-08 加入
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management
6天前
已完结
Health policy and public health implications of obesity in China
30天前
已完结
Health policy and public health implications of obesity in China
30天前
已完结
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
1个月前
已完结
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
1个月前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
1个月前
已完结
Impact of ectopic fat on brain structure and cognitive function: A systematic review and meta-analysis from observational studies
1个月前
已完结
Insufficient sleep syndrome: An unrecognized but important clinical entity
2个月前
已关闭
皖公网安备34019202002308
